Skip To Content

For Researchers

Fighting Blindness Canada has contributed over $40 million to support vision research and education at hospitals and universities across Canada.

If you are interested in applying for one of our grant programs, please fill out the applicable forms below. All submissions are reviewed by our expert Scientific Advisory Board.

FBC Grants


The 2019 Grant Competition will support independent investigators and/or research teams with a principal investigator from a Canadian institution who share our goal of developing new therapies that have the potential to transform the lives of people living with blindness and vision loss.

NEW: Research related to all blinding eye diseases will be considered.

Duration of Award: Funding is based on a 24-month period


May 15, 2019: Deadline to submit Letter of Intent 

2019 Grant Competition: Full Proposal Instructions and Evaluation Criteria

2019 Grant Competition Cover Form (PDF)  |  2019 Grant Competition Cover Form (Word)

Please use either the PDF or word version of the cover form.

August 15, 2019: Deadline to submit Full Proposal 

FBC Research Grant Application Letter of Intent General Guidelines WORD

2019 Budget Module 

Submit Full Proposal


Clinician-scientist ophthalmologists play an essential role in developing new sight-saving treatments. FBC’s Clinician-Scientist Emerging Leader (CSEL) Award aims to strengthen the community of clinician-scientists with ophthalmological expertise in Canada by enabling the next generation of ophthalmologists to incorporate research into their careers. In 2018, FBC is proud to announce a new partnership with Bayer that will allow us to support more emerging leaders, who will fuel our fight against blindness!


August 15, 2019: Deadline to submit Full Proposal

FBC Clinician-Scientist Emerging Leader Award Terms of Reference PDF

Submit Application

FBC Policies & Positions

Created and Implemented September 17, 2014

Fighting Blindness Canada (FBC) has implemented a patent rights policy for FBC-funded research. The policy can be downloaded here: PDF

Created March 22, 2010

Stem cell research holds promise for finding treatments for various retinal dystrophies. Fighting Blindness Canada (FBC) is committed to finding treatments for retinal dystrophies and supports stem cell research as per the Assisted Human Reproduction Act (AHRA), which became law in Canada in March 2004. The Act and its framework ensure the consistent and regulated conduct of research, which balances respect for human life and potential for modern science. FBC acknowledges the highly sensitive and ethical issues addressed by the Act concerning embryonic stem cell research, and supports efforts to identify alternative sources for therapeutic applications. FBC respects all points of view on this important topic.

For details about Assisted Human Reproduction in Canada visit

If you wish not to support embryonic stem cell research, your donation to FBC can be directed to alternative sources for therapeutic applications, such as gene therapy or to education and public awareness.

Created May 2007

Fighting Blindness Canada (FBC) does not provide funds for indirect costs associated with research. While FBC recognizes that these are indeed legitimate expenditures, we believe the funding of such costs is the responsibility of governments and/or research institutions – not donors.

Fighting Blindness Canada is a member in good standing of the Health Charities Coalition of Canada (HCCC). All HCCC members abide by this funding policy. See the HCCC position statement on indirect costs.

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.

I have read and accepted the privacy policy